ORAGENICS INC (OGEN) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K/A	10-K/A	10-K	10-K	10-K	10-K	10-K	10-K
Assets
Current assets:
Cash and cash equivalents	27.3	17.6	18.3	20.2	6.2	4.1	5.1	10.4
Other receivables	0.0
Prepaid expenses and other current assets	0.4	0.3	0.6	1.7	1.0	0.1	0.2	0.1
Total current assets	27.7	18.0	18.8	21.9	7.2	4.2	5.6	11.0
Property and equipment, net	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1
Operating lease right-of-use assets	0.5	0.7	0.8
Total assets	28.2	18.7	19.8	22.0	7.2	4.3	5.8	11.1

Liabilities and Shareholders’ Equity
Current liabilities:
Accounts payable and accrued expenses	0.9	0.9	1.5	1.0	0.8	1.3	0.8	0.7
Short-term notes payable	0.3	0.2	0.1
Total current liabilities	1.4	1.3	1.9	1.2	0.9	1.3	1.0	0.8

Long-term liabilities:
Total long-term liabilities	0.3	0.5	0.7

Shareholders’ equity:
Preferred stock, no par value; 50,000,000 shares authorized; 5,417,000 and 5,417,000 Series A shares, 4,050,000 and 4,050,000 Series B shares, -0- and -0- Series C shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively	2.7	7.2	6.5	6.1	6.3
Common stock	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0
Additional paid-in capital	195.0	164.0	138.0	126.1	101.4	97.7	92.3	86.2
Accumulated deficit	-171.3	-154.4	-127.4	-111.4	-101.4	-94.7	-87.7	-75.9
Total shareholders’ equity	26.5	16.8	17.2	20.9	6.3	3.0	4.7	10.3
Total liabilities and shareholders’ equity	28.2	18.7	19.8	22.0	7.2	4.3	5.8	11.1